Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1027

Similar articles for PubMed (Select 21208549)

1.

Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.

Hardelid P, Andrews NJ, Hoschler K, Stanford E, Baguelin M, Waight PA, Zambon M, Miller E.

Health Technol Assess. 2010 Dec;14(55):115-92. doi: 10.3310/hta14550-03.

2.

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M.

Lancet. 2010 Mar 27;375(9720):1100-8. doi: 10.1016/S0140-6736(09)62126-7. Epub 2010 Jan 21.

PMID:
20096450
3.

Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.

Puleston RL, Bugg G, Hoschler K, Konje J, Thornton J, Stephenson I, Myles P, Enstone J, Augustine G, Davis Y, Zambon M, Nicholson KG, Nguyen-Van-Tam JS.

Health Technol Assess. 2010 Dec;14(55):1-82. doi: 10.3310/hta14550-01.

4.

Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.

Delangue J, Salez N, Ninove L, Kieffer A, Zandotti C, Seston M, Lina B, Nougairede A, Charrel R, Flahault A, de Lamballerie X.

Clin Microbiol Infect. 2012 Feb;18(2):177-83. doi: 10.1111/j.1469-0691.2011.03545.x. Epub 2011 Jun 2.

5.

A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart.

Nicholson KG, Abrams KR, Batham S, Clark TW, Hoschler K, Lim WS, Medina M, Nguyen-Van-Tam JS, Read RC, Warren FC, Zambon M.

Health Technol Assess. 2010 Dec;14(55):193-334. doi: 10.3310/hta14550-04.

6.

Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India.

Tandale BV, Pawar SD, Gurav YK, Chadha MS, Koratkar SS, Shelke VN, Mishra AC.

BMC Infect Dis. 2010 Aug 25;10:255. doi: 10.1186/1471-2334-10-255.

7.

Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter.

Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, Dwyer DE.

PLoS One. 2010 Sep 7;5(9):e12562. doi: 10.1371/journal.pone.0012562.

8.

Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.

Van Kerkhove MD, Hirve S, Koukounari A, Mounts AW; H1N1pdm serology working group.

Influenza Other Respir Viruses. 2013 Sep;7(5):872-86. doi: 10.1111/irv.12074. Epub 2013 Jan 21. Review.

PMID:
23331969
9.

Seroprevalence study of antibodies against influenza A(H1N1) 2009 virus after the second pandemic wave in Slovenia.

Subelj V, Prosenc K, Sočan M.

Wien Klin Wochenschr. 2012 Mar;124(5-6):177-80. doi: 10.1007/s00508-012-0126-0. Epub 2012 Feb 15.

PMID:
22327938
10.

Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period.

Rizzo C, Rota MC, Bella A, Alfonsi V, Declich S, Caporali MG, Ranghiasci A, Lapini G, Piccirella S, Salmaso S, Montomoli E.

Vaccine. 2010 Apr 30;28(20):3558-62. doi: 10.1016/j.vaccine.2010.03.006. Epub 2010 Mar 20.

PMID:
20307592
11.

Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?

Allwinn R, Geiler J, Berger A, Cinatl J, Doerr HW.

Med Microbiol Immunol. 2010 May;199(2):117-21. doi: 10.1007/s00430-010-0143-4. Epub 2010 Feb 17.

PMID:
20162304
13.

Prevalence of seropositivity to pandemic influenza A/H1N1 virus in the United States following the 2009 pandemic.

Reed C, Katz JM, Hancock K, Balish A, Fry AM; H1N1 Serosurvey Working Group.

PLoS One. 2012;7(10):e48187. doi: 10.1371/journal.pone.0048187. Epub 2012 Oct 31.

14.

Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

Skowronski DM, Hottes TS, McElhaney JE, Janjua NZ, Sabaiduc S, Chan T, Gentleman B, Purych D, Gardy J, Patrick DM, Brunham RC, De Serres G, Petric M.

J Infect Dis. 2011 Jan 15;203(2):158-67. doi: 10.1093/infdis/jiq039.

15.

Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.

McVernon J, Laurie K, Barr I, Kelso A, Skeljo M, Nolan T.

Influenza Other Respir Viruses. 2011 Jan;5(1):7-11. doi: 10.1111/j.1750-2659.2010.00172.x. Epub 2010 Aug 24.

PMID:
21138535
16.

Cumulative incidence of pandemic influenza A (H1N1) 2009 by a community-based serological cohort study in Selenghe Province, Mongolia.

Burmaa A, Tsatsral S, Odagiri T, Suzuki A, Oshitani H, Nymadawa P.

Influenza Other Respir Viruses. 2012 Nov;6(6):e97-e104. doi: 10.1111/j.1750-2659.2012.00334.x. Epub 2012 Feb 13.

PMID:
22329794
17.

Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.

Maruszak H, Jeganathan S, Smith DE, Robertson P, Barnes T, Furner V.

HIV Med. 2012 Jul;13(6):352-7. doi: 10.1111/j.1468-1293.2011.00987.x. Epub 2012 Feb 2.

PMID:
22296264
18.

Factors associated with infection by 2009 pandemic H1N1 influenza virus during different phases of the epidemic.

Chao DY, Cheng KF, Li TC, Wu TN, Chen CY, Tsai CA, Chen JH, Chiu HT, Lu JJ, Su MC, Liao YH, Chan WC, Hsieh YH; CIDER group.

Int J Infect Dis. 2011 Oct;15(10):e695-701. doi: 10.1016/j.ijid.2011.05.012. Epub 2011 Jul 20.

19.

Age-specific incidence of A/H1N1 2009 influenza infection in England from sequential antibody prevalence data using likelihood-based estimation.

Baguelin M, Hoschler K, Stanford E, Waight P, Hardelid P, Andrews N, Miller E.

PLoS One. 2011 Feb 23;6(2):e17074. doi: 10.1371/journal.pone.0017074.

20.

Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.

Lemaitre M, Leruez-Ville M, De Lamballerie XN, Salez N, Garrone P, Fluckiger AC, Klatzmann D, Carrat F.

Clin Microbiol Infect. 2011 May;17(5):732-7. doi: 10.1111/j.1469-0691.2010.03352.x. Epub 2010 Oct 29.

PMID:
20731679
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk